An enzyme known as PI3K gamma may be able to reduce organ and tissue damage in patients who have COVID-19 or drug-resistant Staphylococcus aureus, researchers at the University of California San Diego found.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
